World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000010752
Date of registration: 17/05/2013
Prospective Registration: Yes
Primary sponsor: Kansai Medical University
Public title: A study on usefulness and safety of donepezil for cognitive function and phychological symptoms of patients with Parkinson's disease and Alzheimer type dementia.
Scientific title: A study on usefulness and safety of donepezil for cognitive function and phychological symptoms of patients with Parkinson's disease and Alzheimer type dementia. - Donepezil study on Parkinson\'s disease with dementia
Date of first enrolment: 2013/05/17
Target sample size: 50
Recruitment status: Complete: follow-up complete
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012567
Study type:  Interventional
Study design:  Single arm Non-randomized  
Phase:  Not selected
Countries of recruitment
Japan
Contacts
Name:     Satoshi Kaneko
Address:  2-5-1 Shinmachi, Hirakata Japan
Telephone: 072-804-2542
Email: kanekosa@takii.kmu.ac.jp
Affiliation:  Kansai Medical University Department of Neurology
Name:     Satoshi Kaneko
Address:  2-5-1 Shinmachi, Hirakata Japan
Telephone: 072-804-2542
Email: kanekosa@takii.kmu.ac.jp
Affiliation:  Kansai Medical University Department of Neurology
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: 1)Patients or their families disagreed to this study 2)Who have been already treated with anti-dementia drugs. 3)Past medical history of severe neurological or psychological disorders (brain tumor, schizophrenia, epilepsy, normal pressure hydrocephalus, mental retardation, head injury associated with loss of consciousness, neurosurgery with residual symptoms). 4)Who have been regarded to be inappropriate to participate in the study.

Age minimum: Not applicable
Age maximum: Not applicable
Gender: Male and Female
Health Condition(s) or Problem(s) studied
Parkinson's disease
Intervention(s)
donepezil
Primary Outcome(s)
UPDRS,MMSE
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Kansai Medical University
Secondary Sponsor(s)
Ethics review
Status: YES
Approval date:
Contact:
Results
Results available: Yes
Date Posted:
Date Completed: 16/05/2015
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history